IL249355A0 - Compound for diabetic mellitus type 2 and insulin resistance - Google Patents

Compound for diabetic mellitus type 2 and insulin resistance

Info

Publication number
IL249355A0
IL249355A0 IL249355A IL24935516A IL249355A0 IL 249355 A0 IL249355 A0 IL 249355A0 IL 249355 A IL249355 A IL 249355A IL 24935516 A IL24935516 A IL 24935516A IL 249355 A0 IL249355 A0 IL 249355A0
Authority
IL
Israel
Prior art keywords
compound
insulin resistance
mellitus type
diabetic mellitus
diabetic
Prior art date
Application number
IL249355A
Other languages
Hebrew (he)
Other versions
IL249355B (en
Inventor
Hillel Joseph
Atzmon Gil
Original Assignee
Ehud Ziv
Hillel Joseph
Atzmon Gil
Dov Gefel
Rony Kalman
Colin Baxter-Jones
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ehud Ziv, Hillel Joseph, Atzmon Gil, Dov Gefel, Rony Kalman, Colin Baxter-Jones filed Critical Ehud Ziv
Priority to IL249355A priority Critical patent/IL249355B/en
Publication of IL249355A0 publication Critical patent/IL249355A0/en
Priority to PCT/IL2017/051307 priority patent/WO2018100581A2/en
Publication of IL249355B publication Critical patent/IL249355B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL249355A 2016-12-01 2016-12-01 Compound for treating diabetes mellitus type 2 and insulin resistance IL249355B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL249355A IL249355B (en) 2016-12-01 2016-12-01 Compound for treating diabetes mellitus type 2 and insulin resistance
PCT/IL2017/051307 WO2018100581A2 (en) 2016-12-01 2017-11-30 Compound for diabetes mellitus type 2 and insulin resistance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL249355A IL249355B (en) 2016-12-01 2016-12-01 Compound for treating diabetes mellitus type 2 and insulin resistance

Publications (2)

Publication Number Publication Date
IL249355A0 true IL249355A0 (en) 2017-04-02
IL249355B IL249355B (en) 2018-05-31

Family

ID=58669510

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249355A IL249355B (en) 2016-12-01 2016-12-01 Compound for treating diabetes mellitus type 2 and insulin resistance

Country Status (2)

Country Link
IL (1) IL249355B (en)
WO (1) WO2018100581A2 (en)

Also Published As

Publication number Publication date
WO2018100581A2 (en) 2018-06-07
WO2018100581A9 (en) 2018-07-26
IL249355B (en) 2018-05-31

Similar Documents

Publication Publication Date Title
ZA201608764B (en) Composition for treating diabetes mellitus comprising insulin and a glp-1/glucagon dual agonist
GB2550097B (en) Cannula with proximally mounted camera
ZA201800511B (en) Rapid-acting insulin compositions
EP3341404A4 (en) Novel insulin analogs and use thereof
IL285613A (en) Improved peptide pharmaceuticals for insulin resistance
IL246757B (en) Novel insulin derivatives and the medical uses hereof
EP3538141A4 (en) Ilt3 ligand
IL257173A (en) Novel insulin derivatives and the medical uses hereof
EP3449962A4 (en) Medical needle with protector
EP3511321A4 (en) Organic light-emitting element, and light-emitting material and compound for use therein
IL254496A0 (en) Treatment type 2 diabetes mellitus patients
EP3280450A4 (en) Glucose-responsive insulin conjugates
EP3348297A4 (en) Syringe with filter
ZA201606836B (en) Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity
ZA201901095B (en) Insulin analogs
IL274693A (en) Syringe assembly with ion-exchange material
IL249355A0 (en) Compound for diabetic mellitus type 2 and insulin resistance
EP3013958A4 (en) Glucan-encapsulated sirna for treating type 2 diabetes mellitus
EP3597177A4 (en) Glucose infusion solution composition
GB201805280D0 (en) Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity
IL270975A (en) Rapid-acting insulin compositions
GB201604099D0 (en) Insulin biosensor
AU2016902883A0 (en) Insulin Analogs
AU2015900877A0 (en) Diabetes hypoalert iwatch

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed